title: [Tamoxifen and cardiovascular risk].
authors.affiliation: Service de Médecine Interne et Pathologie Vasculaire, Hôpital Saint-Louis, Paris.
authors.forename: D
authors.initials: D
authors.lastname: Farge
authors.forename: B
authors.initials: B
authors.lastname: Chanu
authors.forename: P
authors.initials: P
authors.lastname: Debourdeau
authors.forename: F
authors.initials: F
authors.lastname: Sauvaget
authors.forename: M
authors.initials: M
authors.lastname: Espie
authors.forename: A
authors.initials: A
authors.lastname: Gorins
authors.forename: J
authors.initials: J
authors.lastname: Rouffy
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008055:Lipids / Q000097:blood; D013629:Tamoxifen / Q000009:adverse effects*; D013923:Thromboembolism / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced
chemical_list: D008055:Lipids; D013629:Tamoxifen
vernacular_title: Tamoxifène et risque cardio-vasculaire.